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Specialist Supportive Clinical Management (SSCM) is a psychotherapy comprising a clinical manage-ment focus addressing anorexia nervosa symptoms 
(AN) and a supportive therapy component. It was devel-
oped as a non-specific active control for a randomised 
controlled trial (RCT) for AN.1* Against hypothesis, 
SSCM was more effective than two specialised psycho-
therapies: cognitive behaviour therapy (CBT) and inter-
personal psychotherapy (IPT).
SSCM has been found to be efficacious, but not signifi-
cantly different, on primary outcomes and most second-
ary outcomes from the more complex, theoretically 
informed psychotherapies in five subsequent RCTs.2–6 In 
addition to the original comparison with CBT and IPT, 
SSCM has been compared to the Maudsley Model of 
Anorexia Nervosa Treatment for Adults (MANTRA) three 
times2–4 and with enhanced cognitive therapy (CBT-E) 
once.4 It has been adapted twice, being compared with 
adapted CBT for severe and enduring AN5; adapted for 
eating disorders (not just AN); and compared with a 
mentalisation-based treatment in those with comorbid 
borderline personality disorder and eating disorders.6
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Abstract
Objective: Specialist Supportive Clinical Management (SSCM) is a psychotherapy comprising a clinical manage-
ment focus addressing anorexia nervosa (AN) symptoms and a supportive therapy component. SSCM has been an 
active control therapy in randomised controlled trials for AN, but has proven to be an effective therapy in its own 
right. There has been speculation about how this relatively straightforward therapy works. Some of the commentar-
ies and descriptors used for SSCM, however, do not reflect the content or principles of SSCM. This paper clarifies 
areas of misunderstanding by describing what SSCM is and what it is not, particularly in relation to commentary 
about its constituent characteristics.
Conclusions: SSCM utilises well established clinical management for AN (with a sustained focus on normalised 
eating and weight restoration) coupled with supportive therapy principles and strategies. Common factors across 
both arms include core counselling skills and a positive therapeutic alliance to promote adherence and retention in 
treatment for AN. Compared to other comparator therapies to date, SSCM is a simpler therapy without unique or 
novel theoretically derived strategies. Comparable outcomes with more complex psychotherapies raise the question 
of whether the combined core components of SSCM may be sufficient for many people with AN.
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SSCM has been found to be effective in six RCTs and 
now appears in treatment guidelines in four countries.7 
The current evidence base for SSCM has led to curiosity 
about why it might work and about its active ingredi-
ents. Compared to other more complex therapies, SSCM 
is relatively simple and less defined. Indeed in the RCTs, 
SSCM has been defined more by what isn’t included.
Recently, several commentaries on SSCM have described 
SSCM using terms not used by the originators. Waller 
and Raykos for example included SSCM in a review of 
behavioural interventions.8 Gutierrez9,10 has described 
SSCM as a placebo and a non-specific treatment in our 
RCT. In SSCM training workshops, some speculate that 
due to tailoring the focus of supportive therapy to the 
patient need, that it could be seen as eclectic. Others 
have speculated that the effectiveness of SSCM might be 
just due to common factors. Given the potential for con-
fusion, it is important to address these issues point by 
point and to clarify what SSCM is and what it is not.
Aim
The aim of this paper is to respond to these commentar-
ies and clarify what is included (or not) in this effective 
therapy.
SSCM: what it is
SSCM is an outpatient psychotherapy for AN, designed 
to be delivered by a clinician with knowledge of basic 
psychotherapy skills and the features and core clinical 
management tasks for AN. The origins and content of 
SSCM have been described previously by the original 
team11 and recently for SSCM-severe and enduring.12 
As its name suggests, SSCM comprises two core ele-
ments, and both are delivered within each session: 
clinical management for AN (focusing on normalising 
eating and weight gain, addressing other AN-related 
behaviours and effects, psychoeducation, and support 
to enhance adherence), and the supportive therapy 
element (focussed on life issues raised by the patient). 
Overlapping and distinct components in the original 
trial1 are illustrated in Table 1.
Clinical management modules were common across 
SSCM and CBT in the original trial. All therapies used 
common factors such as establishing and maintaining a 
trusting therapeutic alliance to retain patients in therapy 
and facilitate change. The patient-driven supportive 
therapy focus was unique to SSCM.
SSCM has three phases. Phase 1 orients the patient to 
SSCM, building shared understanding through the use 
of the straightforward atheoretical model (a linear path 
from dieting and weight loss to AN, with resulting 
physical, psychological and psychosocial effects); estab-
lishing target symptoms, setting target symptom and 
goal weight ranges; and commencing the provision of 
relevant psychoeducation about physical and psycho-
social aspects of AN. Phase 2 has a sustained focus on 
normalised eating and weight gain. The final phase 
continues core tasks, but includes a termination focus, 
reflecting back on helpful aspects and strategies, high-
lighting patient strengths, looking ahead at maintain-
ing change, anticipating hurdles and how to deal with 
them, and the process of saying goodbye. The support-
ive therapy aspect of each session continues through-
out the treatment.
SSCM is a pragmatic, transparent, adopting a common-
sense, responsive approach to the needs of the patient. 
The therapist stance utilises characteristics of effective 
therapists: attentiveness, warmth, empathy, authentic-
ity, non-judgmental, affirming and supportive stance, 
respecting and working with patient defences. The ther-
apist is active and a change focus is present in both arms.
SSCM: what it is not
SSCM does not have:
•• a theoretical model of causation or theory-driven
strategies;
Table 1. Distinct and overlapping features of SSCM compared to other therapies in the original trial.1
SSCM CBT IPT
 • Atheoretical SSCM model
 • Patient-driven focus in supportive
therapy
 • CBT model
 • Sustained focus on cognition and
behaviour
 • IPT model
 • Sustained interpersonal focus
 • Clinical management focus on normalised eating and weight restoration
 • Psychoeducation
 • Positive therapeutic alliance
 • Other non-specific therapy factors
SSCM: Specialist Supportive Clinical Management; CBT: cognitive behaviour therapy; IPT: interpersonal psychotherapy.
•• formal motivational strategies, although clinical
management and supportive therapy use encour-
agement, awareness of physical and psychosocial
costs of AN and of desired areas of life change;
•• homework, apart from the expectation of progress
on normalised eating goals.
SSCM is not:
•• a placebo therapy: SSCM was designed as a bone
fide active control therapy.
•• just common factors or generic psychotherapy:
clinical management has a highly specific AN
symptom focus.
•• behaviour therapy: SSCM focuses on behavioural
change in normalising eating and some principles
apply (e.g. breaking goals into small steps); how-
ever, it does not reference behavioural principles
or require systematic self-monitoring. Supportive
therapy does not overlap with behaviour therapy.
•• eclectic: Although goals for a problem will be simi-
lar across therapies, SSCM is not eclectic in adopt-
ing approaches from other therapies. Any similar
strategies would be implemented in the SSCM
manner i.e. pragmatically, without referencing the-
ory or using technical aspects of other therapies.
Possibly effective components 
of SSCM
The consistent dual focus on the disorder and the per-
son may contribute to the success of SSCM. The direct 
symptom focus is arguably the most effective factor. 
Recovery from AN is hard and weight gain is difficult, 
but non-negotiable. Although some have criticised 
existing psychological models for AN for focussing on 
epiphenomena of starvation,10 there is little argument 
that reversing starvation by directly focussing on nor-
malised eating and weight gain is a necessary compo-
nent across therapies.8
Those with AN though often complain about too much 
focus on eating and weight. SSCM supports patients 
through the challenging process of weight gain, while 
simultaneously recognising their other issues. SSCM’s 
atheoretical model leaves room for the patient’s own 
model and the spaciousness (uncluttered by complex 
technical aspects and modules of other therapies such as 
MANTRA and CBT), and allows more room to listen and 
address their current life issues. Supportive therapy, an 
under-rated modality,13 employs the undoubtedly essen-
tial common factors14 with active strategies to address 
patients’ psychological needs. This collaborative, respect-
ful broader life focus may be attractive and remove barri-
ers to engagement for some.15
Advantages and disadvantages 
of SSCM
Advantages of SSCM include that the dual focus compo-
nents are familiar and widely used clinically. The atheo-
retical, straightforward model and strategies are easy to 
teach, so more easily disseminated to a range of disci-
plines. Working with patient defences allows flexibility 
in how tasks are approached, potentially enhancing 
patients’ sense of control and lowering resistance (com-
pared to CBT where some patients dislike some strate-
gies such as self-monitoring). Disadvantages include 
that the manual does not provide explicit guidance in 
how to manage all eating disorder behaviours compared, 
for example, to CBT which has theoretically driven 
modules for specific behaviours such as thought chal-
lenging or exposure tasks. The simplicity of SSCM 
means that it does not include potentially engaging 
modules like cognitive remediation in MANTRA. The 
sustained focus on eating and weight is difficult for 
some patients and therapists; however, that issue is not 
unique to SSCM. The dual focus and yet relative sim-
plicity of SSCM have led to some mischaracterisation as 
other writers have tried to position SSCM in relation to 
other psychotherapies.
Conclusions
SSCM has a dual focus incorporating clinical manage-
ment for AN (strong, persistent focus on normalised eat-
ing and weight restoration) with supportive therapy 
(patient-driven focus). SSCM is a streamlined therapy 
without unique or novel theoretical-derived strategies, 
so the somewhat puzzling comparable effectiveness 
against more complex psychotherapies in six RCTs raises 
the question of whether the combined core components 
of SSCM may be sufficient for many with AN, and if so 
why.
Knowledge is lacking about effective elements of SSCM 
and other evidence-supported therapies for AN. Further 
research is needed to compare and examine the relative 
potency of therapy components within and across con-
temporary psychotherapy models to contribute to 
improving outcomes for AN.
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